Alzheimer’s Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is the most common form of dementia. During the recent decade, nanotechnology has been widely considered, as a promising tool, for theranosis (diagnosis and therapy) of AD. Here we first discuss pathophysiology and characteristics of AD with a focus on the amyloid cascade hypothesis. Then magnetic nanoparticles (MNPs) and recent works on their applications in AD, focusing on the superparamagnetic iron oxide nanoparticles (SPIONs), are reviewed. Furthermore, the amyloid-nanoparticle interaction is highlighted, with the scope to be highly considered by the scientists aiming for diagnostics and/or treatment of AD employing nanoparticles. Furthermore, recent findings on the "ignored" parameters (e.g., effect of protein "corona" at the surface of nanoparticles on amyloid-β (Aβ) fibrillation process) are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Protein folding and misfolding
Dobson, C. M. (2003) · Nature · doi:10.1038/nature02261 · Cited by 4,791
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962
Research works printed but not linked: 116
- Selkoe D. J., 2003, Annu. Rev. Pharmacol. Toxicol., 43, 545, 10.1146/annurev.pharmtox.43.100901.140248 · DOI · Paper page
- Mahmoudi M., 2012, Chem. Commun., 48, 3957, 10.1039/c2cc30213f · DOI
- Mahmoudi M., 2012, ACS Nano, 6, 2656, 10.1021/nn300042m · DOI · Paper page
- Helzner E. P., 2008, Neurology, 71, 1489, 10.1212/01.wnl.0000334278.11022.42 · DOI · Paper page
- Folstein M. F., 1975, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
- Berger G., 2008, J. Geriatr. Psychiatry Neurol., 21, 250, 10.1177/0891988708324939 · DOI
- Wilson R. S., 2006, Neuroepidemiology, 26, 61, 10.1159/000090250 · DOI · Paper page
- Mahmoudi M., 2012, Trends Biotechnol., 30, 609, 10.1016/j.tibtech.2012.08.007 · DOI
- Van Dam D., 2006, Nat. Rev. Drug Discovery, 5, 956, 10.1038/nrd2075 · DOI · Paper page
- Allinson T. M., 2003, J. Neurosci. Res., 74, 342, 10.1002/jnr.10737 · DOI · Paper page
- Wisniewski T., 2010, Biochim. Biophys. Acta, Mol. Basis Dis., 1802, 847, 10.1016/j.bbadis.2010.05.004 · DOI · Paper page
- Weller R. O., 2003, Neurol. Res., 25, 611, 10.1179/016164103101202057 · DOI · Paper page
- Maat-Schieman M., 2005, Neuropathology, 25, 288, 10.1111/j.1440-1789.2005.00631.x · DOI · Paper page
- Crawford F., 1998, Exp. Neurol., 150, 159, 10.1006/exnr.1997.6743 · DOI
- Niwa K., 2001, Am. J. Physiol.: Heart Circ. Physiol., 281, H2417
- de la Torre J. C., 2000, Neurobiol. Aging, 21, 331, 10.1016/S0197-4580(00)00111-1 · DOI · Paper page
- Crawford F., 1998, FEBS Lett., 436, 445, 10.1016/S0014-5793(98)01170-3 · DOI · Paper page
- Thomas T., 1997, J. Cardiovasc. Pharmacol., 30, 517, 10.1097/00005344-199710000-00017 · DOI
- Burke S. N., 2010, Trends Neurosci., 33, 153, 10.1016/j.tins.2009.12.003 · DOI · Paper page
- Samuel W., 1994, Neurology, 44, 2081, 10.1212/WNL.44.11.2081 · DOI · Paper page
- Rapp P. R., 1996, Proc. Natl. Acad. Sci. U.S.A., 93, 9926, 10.1073/pnas.93.18.9926 · DOI · Paper page
- Dong H., 2007, J. Comp. Neurol., 500, 311, 10.1002/cne.21176 · DOI · Paper page
- Rademakers R., 2003, Sci. World J., 3, 497, 10.1100/tsw.2003.39 · DOI · Paper page
- Tanzi R. E., 2001, Neuron, 32, 181, 10.1016/S0896-6273(01)00476-7 · DOI · Paper page
- Mayeux., 2003, Annu. Rev. Neurosci., 26, 81, 10.1146/annurev.neuro.26.043002.094919 · DOI · Paper page
- Van Duijn C. M., 1994, Genet. Epidemiol., 11, 539, 10.1002/gepi.1370110609 · DOI · Paper page
- Corder E. H., 1993, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
- Strittmatter W. J., 1993, Proc. Natl. Acad. Sci. U.S.A., 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
- Pitas R. E., 1987, J. Biol. Chem., 6, 63
- Xu P. T., 1999, Neurobiol. Dis., 6, 63, 10.1006/nbdi.1998.0213 · DOI · Paper page
- Mahley R. W., 2000, Annu. Rev. Genomics Hum. Genet., 1, 507, 10.1146/annurev.genom.1.1.507 · DOI · Paper page
- Tierney M. C., 1996, Neurology, 46, 149, 10.1212/WNL.46.1.149 · DOI · Paper page
- Mahley R. W., 2006, Proc. Natl. Acad. Sci. U.S.A., 103, 5644, 10.1073/pnas.0600549103 · DOI · Paper page
- McLean C. A., 1999, Ann. Neurol., 46, 860, 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
- Hardy J., 2002, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
- Li S., 2009, Neuron, 62, 788, 10.1016/j.neuron.2009.05.012 · DOI · Paper page
- Glenner G. G., 1984, Biochem. Biophys. Res. Commun., 120, 885, 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
- Glenner G. G., 1989, Prog. Clin. Biol. Res., 317, 857
- Ikeda S., 1989, Lab. Invest., 60, 113
- Goldgaber D., 1987, Science, 235, 877, 10.1126/science.3810169 · DOI · Paper page
- St George-Hyslop P. H., 1987, Science, 235, 885, 10.1126/science.2880399 · DOI · Paper page
- Levy E., 1990, Science, 248, 1124, 10.1126/science.2111584 · DOI · Paper page
- Selkoe D. J., 1998, Trends Cell Biol., 8, 447, 10.1016/S0962-8924(98)01363-4 · DOI · Paper page
- Bonifacino J. S., 2003, Annu. Rev. Biochem., 72, 395, 10.1146/annurev.biochem.72.121801.161800 · DOI · Paper page
- Yamazaki T., 1996, J. Cell Sci., 109, 999, 10.1242/jcs.109.5.999 · DOI · Paper page
- Koo E. H., 1996, J. Cell Sci., 109, 991, 10.1242/jcs.109.5.991 · DOI · Paper page
- Stokin G. B., 2006, Annu. Rev. Biochem., 75, 607, 10.1146/annurev.biochem.75.103004.142637 · DOI · Paper page
- Tienari P., 1996, EMBO J., 15, 10.1002/j.1460-2075.1996.tb00907.x · DOI
- Roychaudhuri R., 2009, J. Biol. Chem., 284, 4749, 10.1074/jbc.R800036200 · DOI · Paper page
- Bernstein S. L., 2009, Nat. Chem., 1, 326, 10.1038/nchem.247 · DOI · Paper page
- Colletier J. P., 2011, Proc. Natl. Acad. Sci. U.S.A., 108, 16938, 10.1073/pnas.1112600108 · DOI · Paper page
- Rahimi F., 2008, Curr. Alzheimer Res., 5, 319, 10.2174/156720508784533358 · DOI · Paper page
- Sakono M., 2010, FEBS J., 277, 1348, 10.1111/j.1742-4658.2010.07568.x · DOI · Paper page
- Lasagna-Reeves C. A., 2011, J. Biol. Chem., 286, 22122, 10.1074/jbc.M111.236257 · DOI · Paper page
- Glabe C. G., 2006, Neurology, 66, S74, 10.1212/01.wnl.0000192103.24796.42 · DOI · Paper page
- Williams R., 2001, Coord. Chem. Rev., 216, 583, 10.1016/S0010-8545(00)00398-2 · DOI · Paper page
- Laurent S., 2012, RSC Adv., 2, 5008, 10.1039/c2ra01374f · DOI
- 10.1038/srep02782 · DOI
- Tottey S., 2007, Molecular microbiology of heavy metals
- Chamberlain R., 2009, Magn. Reson. Med., 61, 1158, 10.1002/mrm.21951 · DOI · Paper page
- Zerbi V., 2012, Brain Struc. Funct., 218, 1805
- Fazil M., 2012, J. Drug Targeting, 20, 97, 10.3109/1061186X.2011.607499 · DOI
- Gabathuler R., 2010, Neurobiol. Dis., 37, 48, 10.1016/j.nbd.2009.07.028 · DOI · Paper page
- Roney C., 2005, J. Controlled Release, 108, 193, 10.1016/j.jconrel.2005.07.024 · DOI · Paper page
- Tanifum E. A., 2012, PloS One, 7, e48515, 10.1371/journal.pone.0048515 · DOI · Paper page
- Beckmann N., 2011, J. Neurosci., 31, 1023, 10.1523/JNEUROSCI.4936-10.2011 · DOI · Paper page
- Petiet A., 2012, Neurobiol. Aging, 33, 1533, 10.1016/j.neurobiolaging.2011.03.009 · DOI
- Poduslo J. F., 2002, Neurobiol. Dis., 11, 315, 10.1006/nbdi.2002.0550 · DOI · Paper page
- Sillerud L. O., 2013, J. Alzheimer’s Dis., 34, 349, 10.3233/JAD-121171 · DOI · Paper page
- Cai W., 2007, Small, 3, 1840, 10.1002/smll.200700351 · DOI · Paper page
- Cao C. Y., 2013, Sci. Rep., 3, 1024, 10.1038/srep01024 · doi:10.1038/srep01024
- Kanal E., 2012, Magn. Reson. Imaging Clin. North Am., 20, 625, 10.1016/j.mric.2012.08.004 · doi:10.1016/j.mric.2012.08.004
- Othman M., 2011, Org. Biomol. Chem., 9, 4367, 10.1039/c1ob00015b · doi:10.1039/c1ob00015b
- Laurent S., 2004, Bioconjugate Chem., 15, 99, 10.1021/bc034114m · doi:10.1021/bc034114m
- Amiri H., 2011, Magn. Reson. Med., 66, 1715, 10.1002/mrm.22959 · DOI
- Amiri H., 2011, Nanoscale, 3, 1022, 10.1039/C0NR00603C · DOI · Paper page
- Hosseini F., 2013, Colloids Surf., B, 652, 10.1016/j.colsurfb.2012.10.035 · doi:10.1016/j.colsurfb.2012.10.035
- Wang Y. X., 2011, Quant. Imaging Med. Surg., 1, 35
- Yanagisawa D., 2011, Neuroscience, 184, 120, 10.1016/j.neuroscience.2011.03.071 · DOI
- Houshang Amiri, M. S., Andor Veltein, Mark J., van Uden, I., Jolanda, M., and de Vries, Arend Heerschap. (2013) Cell Tracking by 19F MRI:Technical Aspects and Challenges towards Clinical Applications.Submitted for publication. · DOI
- Krol S., 2013, Chem. Rev., 113, 1877, 10.1021/cr200472g · DOI · Paper page
- Mahmoudi M., 2013, ACS Chem. Neurosci., 4, 475, 10.1021/cn300196n · DOI · Paper page
- Cabaleiro-Lago C., 2010, ACS Chem. Neurosci., 1, 279, 10.1021/cn900027u · DOI · Paper page
- Amiri H., 2013, Nanoscale, 5, 8656, 10.1039/c3nr00345k · DOI · Paper page
- Dorota Walczyk B. F., 2010, J. Am. Chem. Soc., 5761
- Mahmoudi M., 2011, Chem. Rev., 111, 5610, 10.1021/cr100440g · DOI · Paper page
- Lesniak A., 2012, ACS Nano, 6, 5845, 10.1021/nn300223w · DOI · Paper page
- Mahmoudi M., 2013, ChemBioChem, 14, 568, 10.1002/cbic.201300007 · DOI
- Mahmoudi M., 2012, Nanoscale, 4, 7322, 10.1039/c2nr31657a · DOI · Paper page
- Mahmoudi M., 2013, ACS Nano, 7, 6555, 10.1021/nn305337c · DOI · Paper page
- Ghavami M., 2013, ACS Chem. Neurosci., 4, 375, 10.1021/cn300205g · DOI
- Mahmoudi M., 2011, ACS Nano, 5, 7263, 10.1021/nn2021088 · DOI · Paper page
- Laurent S., 2013, J. Colloid Interface Sci., 392, 431, 10.1016/j.jcis.2012.10.005 · DOI
- Rauch J., 2012, Sci. Rep., 2, 868, 10.1038/srep00868 · DOI
- Mahmoudi M., 2012, Nanoscale, 4, 5461, 10.1039/c2nr31185b · DOI
- Mahmoudi M., 2011, Chem. Rev., 111, 253, 10.1021/cr1001832 · DOI · Paper page
- Mahmoudi M., 2010, Int. J. Biomed. Nanosci. Nanotechnol., 164, 10.1504/IJBNN.2010.034651 · DOI · Paper page
- Mahmoudi M., 2010, J. Iran. Chem. Soc., 7, S1, 10.1007/BF03246181 · DOI
- Nighoghossian N., 2007, Stroke, 38, 303, 10.1161/01.STR.0000254548.30258.f2 · DOI · Paper page
- Saleh A., 2007, Stroke, 38, 2733, 10.1161/STROKEAHA.107.481788 · DOI · Paper page
- Dousset V., 2006, AJNR Am. J. Neuroradiol., 27, 1000
- Mahmoudi M., 2011, ACS Chem. Neurosci., 2, 118, 10.1021/cn100100e · DOI · Paper page
- Mahmoudi M., 2011, Adv. Drug Delivery Rev., 63, 24, 10.1016/j.addr.2010.05.006 · DOI · Paper page
- Mahmoudi M, 2010, Superparamagnetic iron oxide nanoparticles for biomedical applications
- Brambilla D., 2012, ACS Nano, 6, 5897, 10.1021/nn300489k · DOI · Paper page
- Skaat H., 2009, Nanotechnology, 20, 225106, 10.1088/0957-4484/20/22/225106 · DOI
- Skaat H., 2009, Biochem. Biophys. Res. Commun., 386, 645, 10.1016/j.bbrc.2009.06.110 · DOI
- Skaat H., 2009, J. Biomed. Mater. Res., Part A, 91, 342, 10.1002/jbm.a.32232 · DOI
- Andersson B. V., 2012, Biochem. Biophys. Res. Commun., 419, 682, 10.1016/j.bbrc.2012.02.077 · DOI
- Bellova A., 2010, Nanotechnology, 21, 065103, 10.1088/0957-4484/21/6/065103 · DOI
- Mahmoudi M., 2012, Chem. Rev., 112, 2323, 10.1021/cr2002596 · DOI · Paper page
- Conti B., 2013, Cell, 152, 671, 10.1016/j.cell.2013.01.050 · DOI
- Xiao R., 2013, Cell, 152, 806, 10.1016/j.cell.2013.01.020 · DOI · Paper page
- Vinters H. V., 1998, Acta Neuropathol., 95, 235, 10.1007/s004010050793 · DOI
- Deng Z. J., 2011, Nature Nanotechnol., 6, 39, 10.1038/nnano.2010.250 · DOI · Paper page
- Ahn H. J., 2010, Proc. Natl. Acad. Sci. U.S.A., 107, 21812, 10.1073/pnas.1010373107 · DOI · Paper page
Cited by
Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer’s Disease
Chen, Q., Du, Y., Zhang, K., Liang, Z., Li, J., Yu, H., Ren, R., Feng, J., Jin, Z., Li, F., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b07625 · Cited by 280
“IONCs were used as high-resolution magnetic resonance imaging (MRI) agents for AD.(31-36) Furthermore, methylene blue (MB),(37-40) a small molecular compound inhibiting tau aggregation was loaded into the pores of MSNs.”
MethodNeurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124
Wang, Z., Hu, J., Yang, X., Feng, X., Li, X., Huang, L., & Chan, A. S. C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01417 · Cited by 91
La Barbera, L., Mauri, E., D’Amelio, M., & Gori, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.939855 · Cited by 74
Liu, D., Li, W., Jiang, X., Bai, S., Liu, J., Liu, X., Shi, Y., Kuai, Z., Kong, W., Gao, R., et al. (2019) · Theranostics · doi:10.7150/thno.30649 · Cited by 49
Li, J., Peng, H., Zhang, W., Li, M., Wang, N., Peng, C., Zhang, X., & Li, Y. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c08756 · Cited by 43
A Promising Approach: Magnetic Nanosystems for Alzheimer’s Disease Theranostics
Chaparro, C. I. P., Simões, B. T., Borges, J. P., Castanho, M. A. R. B., Soares, P. I. P., & Neves, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092316 · Cited by 40
Unveiling the theranostic potential of SPIONs in Alzheimer's disease management
Aminyavari, S., Afshari, A. R., Ahmadi, S. S., Kesharwani, P., Sanati, M., & Sahebkar, A. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.09.022 · Cited by 5
Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions
Zorkina, Y., Abramova, O., Zubkov, E., Gurina, O., & Ushakova, V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083560 · Cited by 1
“Numerous preclinical studies target amyloid with theranostic nanoplatforms [39,40].”
Metadata
- Authors
- Amiri, H., Saeidi, K., Borhani, P., Manafirad, A., Ghavami, M., & Zerbi, V.
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-09-26
- Volume
- 4
- Issue
- 11
- Pages
- 1417-1429
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W2064534908
- Cited by
- 113
- References
- 50
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.